CAS RN: 103475-41-8
Tepoxalin
Product Availability
Choose a grade to view its available package options.
10 package records10 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251014 |
10mg |
In stock |
| Inquiry |
| Batchno.20250530 |
1mg |
In stock |
| Inquiry |
| Batchno.20260315 |
25mg |
In stock |
| Inquiry |
| Batchno.20251116 |
50mg |
In stock |
| Inquiry |
| Batchno.20250720 |
5mg |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250810 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251227 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250823 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250706 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260503 |
50mg |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS103475-41-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
103475-41-8 / 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide
TEPOXALIN | Tepoxaline | Zubrin
Standard CAS: 103475-41-8
Multi CAS: Yes
Basic Information
CAS
103475-41-8
Multi CAS
Yes
Molecular Formula
C20H20ClN3O3
Molecular Weight
385.800000
Exact Mass
385.119319
SMILES
CN(C(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)OC)O
InChI
InChI=1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3
InChIKey
XYKWNRUXCOIMFZ-UHFFFAOYSA-N
Synonyms
TEPOXALIN
Tepoxaline
Zubrin
Orf-20485
ORF 20485
Computed Properties
Structural Parameters
Heavy atom count
27
Aromatic heavy atom count
17
Fraction Csp3
0.2
Rotatable bonds
6
H-bond acceptors
5
H-bond donors
1
Molar refractivity
103.44
TPSA
67.59
LogP / Solubility
WLOGP
3.98
MLOGP
3.53
XLogP3
3.4
Consensus LogP
3.64
Log S (ESOL)
-4.81
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.6
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.19
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.25
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5
Safety & Transport
Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement Codes
P264, P270, P301+P317, P330, and P501